Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Cyclooxygenase | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Change (functional) | = -36 % | Percent change in average volume of pleural fluid at a dose 4 mg/kg of indomethacin and 5-h response is evaluated by Evans blue-carrageenan induced pleural effusion assay | ChEMBL. | 6436487 |
Change (functional) | = -15 % | Percent change in avgerage volume of pleural fluid at a dose of 4.0 mg/kg and 5-h response by Evans blue-carrageenan induced pleural effusion assay. | ChEMBL. | 6436487 |
Change (functional) | = -14 % | Percent change in average volume of pleural fluid at a dose of 100 mg/kg and 5-h response by Evans blue-carrageenan induced pleural effusion assay. | ChEMBL. | 6436487 |
IC50 (binding) | = 0.08 uM | Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles. | ChEMBL. | 6436487 |
IC50 (binding) | = 0.08 uM | Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles. | ChEMBL. | 6436487 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.